EMA Explains Procedure For Parallel Review Of Drugs For EU And Non-EU Markets

 
• By Vibha Sharma

Companies can get the European Medicines Agency’s scientific opinion for their products’ use in EU and non-EU countries at about the same time.

pills
The EU-M4all procedure aims to facilitate medicines access in non-EU countries • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards